Atria Investments’s Johnson & Johnson JNJ Stock Holding History

Atria Investments’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$59.3M	Sell	242,714 -4,111	-2%	-$958K	0.66%	25
2025 Q4	$51.1M	Buy	246,825 +4,772	+2%	+$944K	0.58%	26
2025 Q3	$44.9M	Buy	242,053 +3,471	+1%	+$595K	0.51%	33
2025 Q2	$36.4M	Sell	238,582 -4,444	-2%	-$683K	0.43%	35
2025 Q1	$40.3M	Buy	243,026 +36,766	+18%	+$5.75M	0.52%	27
2024 Q4	$29.8M	Buy	206,260 +3,190	+2%	+$494K	0.37%	45
2024 Q3	$32.9M	Buy	203,070 +5,426	+3%	+$865K	0.41%	42
2024 Q2	$28.9M	Sell	197,644 -22,749	-10%	-$3.38M	0.37%	48
2024 Q1	$34.9M	Buy	220,393 +12,971	+6%	+$2.06M	0.48%	38
2023 Q4	$32.5M	Buy	207,422 +626	+0.3%	+$96K	0.5%	38
2023 Q3	$32.2M	Sell	206,796 -585	-0.3%	-$96.5K	0.57%	29
2023 Q2	$34.3M	Buy	207,381 +7,562	+4%	+$1.22M	0.62%	24
2023 Q1	$31M	Buy	199,819 +2,619	+1%	+$423K	0.59%	24
2022 Q4	$34.8M	Buy	197,200 +7,148	+4%	+$1.23M	0.71%	21
2022 Q3	$31M	Buy	190,052 +4,093	+2%	+$693K	0.69%	20
2022 Q2	$33M	Buy	185,959 +16,360	+10%	+$2.91M	0.69%	20
2022 Q1	$30.1M	Buy	169,599 +4,538	+3%	+$772K	0.53%	31
2021 Q4	$28.2M	Sell	165,061 -2,020	-1%	-$331K	0.5%	33
2021 Q3	$27M	Sell	167,081 -316	-0.2%	-$53.9K	0.49%	34
2021 Q2	$27.6M	Buy	167,397 +23,165	+16%	+$3.84M	0.53%	31
2021 Q1	$23.7M	Buy	144,232 +4,781	+3%	+$774K	0.52%	34
2020 Q4	$21.9M	Buy	139,451 +11,612	+9%	+$1.71M	0.53%	28
2020 Q3	$19M	Buy	127,839 +17,598	+16%	+$2.6M	0.58%	30
2020 Q2	$15.5M	Buy	+110,241	New	+$16.1M	0.53%	32
2020 Q1	–	Sell	-133,946	Closed	-$19.5M	–	889
2019 Q4	$19.5M	Buy	133,946 +53,949	+67%	+$7.32M	0.53%	28
2019 Q3	$10.3M	Buy	79,997 +3,845	+5%	+$507K	0.37%	56
2019 Q2	$10M	Buy	76,152 +25,193	+49%	+$3.49M	0.37%	52
2019 Q1	$7.12M	Sell	50,959 -5,666	-10%	-$759K	0.3%	69
2018 Q4	$7.31M	Sell	56,625 -1,295	-2%	-$181K	0.32%	52
2018 Q3	$8M	Buy	57,920 +3,622	+7%	+$481K	0.32%	55
2018 Q2	$6.59M	Buy	54,298 +3,431	+7%	+$428K	0.29%	62
2018 Q1	$6.52M	Buy	50,867 +3,647	+8%	+$493K	0.31%	51
2017 Q4	$6.6M	Sell	47,220 -12,244	-21%	-$1.71M	0.33%	51
2017 Q3	$7.73M	Sell	59,464 -5,346	-8%	-$709K	0.42%	41
2017 Q2	$8.57M	Sell	64,810 -521	-0.8%	-$66.5K	0.52%	31
2017 Q1	$8.14M	Sell	65,331 -5,039	-7%	-$602K	0.53%	31
2016 Q4	$8.11M	Buy	70,370 +9,700	+16%	+$1.12M	0.62%	26
2016 Q3	$7.17M	Buy	60,670 +10,527	+21%	+$1.28M	0.66%	26
2016 Q2	$6.12M	Buy	50,143 +5,655	+13%	+$643K	0.66%	26
2016 Q1	$4.81M	Buy	44,488 +4,224	+10%	+$437K	0.55%	27
2015 Q4	$3.95M	Buy	40,264 +3,369	+9%	+$339K	0.43%	37
2015 Q3	$3.44M	Sell	36,895 -2,545	-6%	-$246K	0.48%	34
2015 Q2	$3.84M	Buy	39,440 +2,939	+8%	+$294K	0.45%	36
2015 Q1	$3.67M	Sell	36,501 -573	-2%	-$58.3K	0.42%	40
2014 Q4	$3.88M	Buy	37,074 +572	+2%	+$60.3K	0.41%	37
2014 Q3	$3.89M	Buy	36,502 +311	+0.9%	+$32.3K	0.4%	41
2014 Q2	$3.79M	Buy	36,191 +918	+3%	+$92.8K	0.38%	44
2014 Q1	$3.46M	Buy	35,273 +551	+2%	+$51.1K	0.35%	45
2013 Q4	$3.18M	Buy	34,722 +549	+2%	+$50.6K	0.32%	53
2013 Q3	$2.96M	Buy	34,173 +1,466	+4%	+$132K	0.31%	56
2013 Q2	$2.81M	Buy	+32,707	New	+$2.78M	0.34%	50

Other funds holding JNJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Atria Investments's JNJ Position: Q1 2026 in Review

Atria Investments reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q1 2026, selling an estimated $958K and leaving 242,714 shares worth $59.3M. The position accounts for 0.66% of the portfolio, ranked #25.

Atria Investments first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

Atria Investments held 242,714 shares of Johnson & Johnson worth $59.3M as of Q1 2026.
Atria Investments sold 4,111 Johnson & Johnson shares in Q1 2026, an estimated $958K.
Johnson & Johnson made up 0.66% of Atria Investments's portfolio in Q1 2026, its #25 holding.
Atria Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.